Last reviewed · How we verify
Vasopressor test
At a glance
| Generic name | Vasopressor test |
|---|---|
| Sponsor | Pontificia Universidad Catolica de Chile |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Unable to electronically communicate with GE monitor
Key clinical trials
- Venous Congestion And Cognitive Dysfunction After Cardiac Surgery
- Modified Shock Index
- Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration
- Discomfort Following Oral Biopsy Comparing Laser and Punch Biopsy (NA)
- Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing, Immunotherapy or Oral Challenges (PHASE1)
- Early Intravenous Hydrocortisone in Sepsis (NA)
- Vasopressor Use Improves Macrocirculation, But What Are Its Effects on Microcirculation? (NA)
- Clinical Assessment of Arterial Dynamic Elastance in ICU Patients, Dependent on Inotropic or Vasopressor Drugs. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vasopressor test CI brief — competitive landscape report
- Vasopressor test updates RSS · CI watch RSS
- Pontificia Universidad Catolica de Chile portfolio CI